Eton Pharmaceuticals (ETON) executive compensation, 2026 proxy

Sean E. Brynjelsen, President and Chief Executive Officer, was paid $2.9M in 2025, up 21% from $2.4M the year before.

Filed
April 24, 2026
Annual meeting
June 9, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.9M+21% vs prior year
CEO pay in equity
63%$1.8M in awards
CEO 2025 Total Pay
$2,914,489Increase from prior year
CEO Salary
$712,433Base salary for 2025
CEO Non-Equity Incentive
$354,792Paid in 2026

How Brynjelsen was paid

$2.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary24%Stock awards32%Option awards31%Non-equity incentive12%All other compensation1%

Named executive officers

ExecutiveTotal
Sean E. BrynjelsenPresident and Chief Executive Officer$2,914,489
James R. GruberChief Financial Officer$1,398,068
David C. KrempaChief Business Officer$1,394,745
Ipek Erdogan-TrinkausChief Commercial Officer$575,292

What changed and why

  • $2.9MCEO total compensation increased to $2,914,489 in 2025 compared to $2,411,923 in 2024.
  • $712KMr. Brynjelsen received a base salary of $712,433 and $354,792 in non-equity incentive compensation for 2025.
  • $936KStock awards granted to the CEO in 2025 totaled $936,052 while option awards totaled $893,712.
  • $17,500All other compensation for the CEO consisted of $17,500 in matching 401(k) contributions.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.